Immunomedics, Inc. (NASDAQ: IMMU) today presented a new method of treating advanced pancreatic cancer at the seventh annual Gastrointestinal (GI ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE